GeneDx Holdings (WGS) Cash from Investing Activities Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) Cash from Investing Activities Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | -165.43% |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -8.06% |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | -289.16% |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 1,052.89% |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -16.62% |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | -8,716.16% |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | -38.65% |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | -40.88% |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -1,399.37% |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | 84.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 84.51% |
| Mar 31, 2026 | -83.41% |
| Dec 31, 2025 | -2,033.33% |
| Sep 30, 2025 | 39.56% |
| Jun 30, 2025 | -60.13% |
| Mar 31, 2025 | -1,216.01% |
| Dec 31, 2024 | 89.33% |
| Sep 30, 2024 | 71.41% |
| Jun 30, 2024 | -101.41% |
| Mar 31, 2024 | 282.47% |
| Dec 31, 2023 | -71.39% |
| Sep 30, 2023 | -534.15% |
| Jun 30, 2023 | 91.35% |
| Mar 31, 2023 | 88.19% |
| Dec 31, 2022 | 63.11% |
| Sep 30, 2022 | -18.24% |
| Jun 30, 2022 | -2,807.77% |
| Mar 31, 2022 | 21.65% |
| Dec 31, 2021 | 98.26% |
| Sep 30, 2021 | 99.18% |